Baker Bros. Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.1M | Buy |
|
|||||
|
2025
Q1 | $4.58M | Hold |
|
|||||
|
2024
Q4 | $7.51M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $6.05M | Sell |
|
|||||
|
2020
Q3 | $2.43M | Sell |
|
|||||
|
2020
Q2 | $2.7M | Hold |
|
|||||
|
2020
Q1 | $1.57M | Hold |
|
|||||
|
2019
Q4 | $1.89M | Hold |
|
|||||
|
2019
Q3 | $1.72M | Hold |
|
|||||
|
2019
Q2 | $2.1M | Hold |
|
|||||
|
2019
Q1 | $2.19M | Hold |
|
|||||
|
2018
Q4 | $1.75M | Sell |
|
|||||
|
2018
Q3 | $5.51M | Sell |
|
|||||
|
2018
Q2 | $15M | Sell |
|
|||||
|
2018
Q1 | $17.6M | Sell |
|
|||||
|
2017
Q4 | $22M | Buy |
|
|||||
|
2017
Q3 | $26.4M | Hold |
|
|||||
|
2017
Q2 | $17M | Hold |
|
|||||
|
2017
Q1 | $15M | Hold |
|
|||||
|
2016
Q4 | $13.9M | Hold |
|
|||||
|
2016
Q3 | $18.1M | Hold |
|
|||||
|
2016
Q2 | $22.7M | Buy |
|